Honokiol not only decreases the interaction between nNOS and PSD95 but also inhibits the translocation of nNOS from the cytosol to the membrane, which finally disrupts NR2B-PSD95-nNOS complex and improves the outcome of ischemic stroke in mice [84]. The gene discussed is NOS1; the disease is ischemic stroke.